Dextera Surgical, Inc. (NASDAQ:DXTR) Files An 8-K Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
The outstanding capital stock of Dextera Surgical Inc. as of the
close of business on June 7, 2017, was as follows:
| Shares of Common Stock: | 26,771,371 |
| Shares of Series A Convertible Preferred Stock: | |
| Shares of Series B Convertible Preferred Stock: | 3,701 |
About Dextera Surgical, Inc. (NASDAQ:DXTR)
Dextera Surgical Inc., formerly Cardica, Inc., designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons. Its MicroCutter 5/80 is a commercially available cartridge-based microcutter device with approximately five millimeter shaft diameter, over 80 degrees of articulation, and an approximately 30 millimeter staple line cleared for specified indications for use in the United States, and in the European Union (EU) for a range of indications for use. It designs, manufactures and markets automated anastomotic systems used by surgeons to perform anastomoses during on- or off-pump coronary artery bypass graft procedures and these products include the C-Port xA system, the C-Port Flex A system and the PAS-Port Proximal Anastomosis System.
